Results 31 to 40 of about 32,766 (214)

Preclinical and clinical development of preventive rotavirus vaccines: special considerations

open access: yesБиопрепараты: Профилактика, диагностика, лечение
INTRODUCTION. Vaccination is recognised as the only effective method for preventing rotavirus disease. Rotavirus remains a leading cause of death in young children, mainly, in developing countries.
A. S. Korovkin   +3 more
doaj   +1 more source

Trends and measurement of HIV prevalence in northern Malawi.

open access: yes, 2003
BACKGROUND: Most data on HIV prevalence in Malawi come from antenatal clinic (ANC) surveillance and are, therefore, subject to bias. OBJECTIVES: HIV prevalence and risk factors were measured using population-based data to assess the accuracy of ANC ...
Crampin, Amelia C   +6 more
core   +1 more source

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium : case-control study [PDF]

open access: yes, 2012
Objective : To evaluate the effectiveness of rotavirus vaccination among young children in Belgium. Design : Prospective case-control study. Setting : Random sample of 39 Belgian hospitals, February 2008 to June 2010.
A. Vergison   +18 more
core   +1 more source

ROTAVIRUS VACCINATION

open access: yesMedical Council, 2016
Rotavirus (RV) infection (RVI) which causes acute gastroenteritis (RVGE) is among the most common infectious diseases in children in both developing and developed countries. Before the name RV was invented, the disease was designated as “toxic dyspepsia”, “our cholera” - “cholera nostra”.
openaire   +3 more sources

Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2021
In the decade since oral rotavirus vaccines (ORV) were recommended by the World Health Organization for universal inclusion in all national immunization programs, significant yet incomplete progress has been made toward reducing the burden of rotavirus ...
Benjamin Lee
doaj   +1 more source

The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]

open access: yes, 2014
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER   +23 more
core   +1 more source

A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay

open access: yesViruses, 2023
Despite the success of rotavirus vaccines, rotaviruses remain one of the leading causes of diarrheal diseases, resulting in significant childhood morbidity and mortality, especially in low- and middle-income countries. The reverse genetics system enables
Jiajie Wei   +13 more
doaj   +1 more source

Advances in enteric disease vaccines: from innovation to implementation [PDF]

open access: yes, 2014
The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core   +1 more source

Diversity Patterns of Domestic Herbivore Viruses in China Reveal Transmission Dynamics with Disease Management Implications

open access: yesAdvanced Science, EarlyView.
This study performs pan‐viromic profiling of 14,529 samples from 5,710 domestic herbivores across five Chinese provinces, establishing the DhCN‐Virome (1,085,360 viral metagenomes). It reveals species/sample‐specific viromic signatures and cross‐species transmission dynamics, aiding unified disease control.
Yue Sun   +19 more
wiley   +1 more source

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

open access: yesThe Lancet Global Health, 2021
Summary: Background: Middle-income countries (MICs) that are not eligible for funding from Gavi, the Vaccine Alliance, have been slow to adopt rotavirus vaccines.
Frédéric Debellut, MSc   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy